Erythroderma Psoriasis
Case Report
DOI:
https://doi.org/10.55175/cdk.v52i3.1158Keywords:
Organ failure, psoriasis, erythrodermic psoriasisAbstract
Introduction: Erythrodermic psoriasis (EP) is a rare type of psoriasis and can be life-threatening. EP requires intensive observation because the large area of the scaly skin increases the risk of secondary infection and sepsis, disrupts the regulation of body temperature, and causes loss of protein, electrolytes, and fuids. Case: Male, 37 years old, with reddish and scaly skin all over the body since 1 day, accompanied by pain and itch. The patient had a history of psoriasis with routine treatment. Discussion: Diagnosis is based on history and typical clinical fndings. The management is intravenous fuids, antibiotics, corticosteroids, antihistamines, and a combination of topical therapy. Conclusion: Erythrodermic psoriasis (EP) is a rare and potentially life-threatening type of psoriasis that requires close bservation, as it can lead to shock and organ failure.
Downloads
References
Michalek IM, Loring B, John SM. Global report on psoriasis. Geneva, Switzerland: World Health Organization; 2016.
Singh R, Lee K, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, et al. Erythrodermic psoriasis: Pathophysiology and current treatment perspectives. Psoriasis Targets Ther. 2016; 6:93–104. DOI: 10.2147/PTT.S101232.
Maharani S, Setyaningrum T. Profl pasien eritroderma. Berkala Ilmu Kesehatan Kulit dan Kelamin 2017;9(1):44–51.
Parisi R, Iskandar IYK, Kontopantelis E, Auguestin M, Grifths C, Aschcroft D, et al. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 2020;28;369:m1590. DOI: 10.1136/bmj.m1590. Systematic analysis and modelling study. BMJ. 2020;28;369:m1590. DOI: 10.1136/bmj.m1590.
Feldman SR. Psoriasis: Epidemiology, clinical manifestations, and diagnosis [Internet]. 2019 [cited 2023 Dec 01]. Available from: https://www.uptodate.com/contents/psoriasis-epidemiology-clinical-manifestations-and-diagnosis.
Susanto PM. Tatalaksana psoriasis eritroderma. Jurnal Medika Hutama 2022;3(2):2292–302.
Suryawati N, Praharsini IGAA. Laporan kasus seri: Pemeriksaan dermoskopi pada kasus eritroderma psoriasis. Berkala Ilmu Kesehatan Kulit dan Kelamin 2018;30(2):111–6. DOI: 10.20473/bikk.V30.2.2018.111-116.
Lui H. Plaque Psoriasis. Medscape [Intenet]. 2021 [cited on: 2023 Des 01]. Available from: https://emedicine.medscape.com/article/1108072-overview.
Lo Y, Tsai T. Updates on treatment of erythrodermic psoriasis. Psoriasis Targets Ther. 2021;11:59–73. DOI: 10.2147/PTT.S288345.
Djuanda A. Eritroderma. In: Djuanda A, Kosasih A, Wiryadi BE, Natahusada EC, Sjamsoe-Daili E, Efendi EH, editors. Ilmu penyakit kulit dan kelamin.
th Ed. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2017 .p. 228–30.
Krisnarto E, Novitasari A, Aulirahma DM. Faktor prediktor kualitas hidup pasien psoriasis: Studi cross sectional. J Kedokt Muhammadiyah. 2016;5(1):43–52.
Mistry N, Gupta A, Alavi A, Sibald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care. 2015;28(5):228-36. DOI: 10.1097/01.ASW.0000463573.40637.73.
Shao S, Wang G, Maverakis E, Gudjonsson J. Targeted treatment for erythrodermic psoriasis: Rationale and recent advances. Drugs 2020; 80(6):525-34. DOI: 10.1007/s40265-020-01283-2.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Internat J Molecular Sci. 2019;20:43-7. DOI: 10.3390/ijms20184347.
Susanto PM. Erythrodermic psoriasis in adult male patient treated with systemic corticosteroid: A case report. J Kes Tambusai. 2022;3(1):336–41.
DOI: 10.31004/jkt.v3i1.4269.
Rosenbach M, Hsu S, Korman N, Lebwohl M, Young M, Bebo B, et al. Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(4):655–62. DOI: 10.1016/j.jaad.2009.05.048.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Putu Riska Mordiana, Nyoman Yudha Santosa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
